Literature DB >> 17481466

Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.

Keith G Heinzerling1, Alex H Kral, Neil M Flynn, Rachel L Anderson, Andrea Scott, Mary L Gilbert, Steven M Asch, Ricky N Bluthenthal.   

Abstract

We described the availability and outcomes of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) testing services at syringe exchange programs throughout California, using interviews with 24 syringe exchange program directors and 560 syringe exchange clients. Both HIV and HCV testing services were available in 62% of programs, 21% had HIV testing only, and 17% had neither. Programs administered by health care/social service providers were more likely than independent syringe exchange programs to have HIV and HCV testing services available. Among clients of programs with testing available, clients of illegal programs were significantly less likely than clients of legal programs to have used syringe exchange HIV and HCV testing services. The availability of HIV and HCV testing services at syringe exchange programs varies, and the use of existing testing services by clients is not universal. Efforts to increase both the availability of HIV and HCV testing services at syringe exchange programs and the use of existing testing services are needed.

Entities:  

Mesh:

Year:  2007        PMID: 17481466     DOI: 10.1016/j.jsat.2006.11.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  6 in total

1.  Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies.

Authors:  Traci C Green; Ricky N Bluthenthal; Merrill Singer; Leo Beletsky; Lauretta E Grau; Patricia Marshall; Robert Heimer
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

2.  The Significance of Harm Reduction as a Social and Health Care Intervention for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program in Fresno, California.

Authors:  Kris Clarke; Debra Harris; John A Zweifler; Marc Lasher; Roger B Mortimer; Susan Hughes
Journal:  Soc Work Public Health       Date:  2016-05-11

3.  Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists.

Authors:  Valerie J Rose; Alexandra Lutnick; Alex H Kral
Journal:  J Psychoactive Drugs       Date:  2014 Jul-Aug

4.  Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California.

Authors:  Paulo Telles Dias; Judith A Hahn; Eric Delwart; Brian Edlin; Jeff Martin; Paula Lum; Jennifer Evans; Alex Kral; Steve Deeks; Michael P Busch; Kimberly Page
Journal:  BMC Infect Dis       Date:  2011-08-02       Impact factor: 3.090

Review 5.  Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.

Authors:  Ricardo M Fernandes; Maria Cary; Gonçalo Duarte; Gonçalo Jesus; Joana Alarcão; Carla Torre; Suzete Costa; João Costa; António Vaz Carneiro
Journal:  BMC Public Health       Date:  2017-04-11       Impact factor: 3.295

6.  Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.

Authors:  Umedjon Ibragimov; Katherine E Cooper; Evan Batty; April M Ballard; Monica Fadanelli; Skylar B Gross; Emma M Klein; Scott Lockard; April M Young; Hannah L F Cooper
Journal:  Harm Reduct J       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.